Björn W. Hackanson
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
Papers in
- Hematology 36
- Acute Myeloid Leukemia Research 32
- Chronic Myeloid Leukemia Treatments 6
- Genetics 10
- Co-authors
- Michael Lübbert (23 shared papers)Manfred Jung (2 shared papers)Julia M. Wagner (1 shared paper)Christoph Plass (8 shared papers)Michael Daskalakis (2 shared papers)Rainer Claus (10 shared papers)Romulo Martin Brena (2 shared papers)Claudia Schmoor (5 shared papers)
- Journals
- Blood (9 papers)Annals of Oncology (5 papers)Annals of Hematology (4 papers)PLoS ONE (3 papers)Cancer Research (3 papers)
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Björn W. Hackanson
59 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 96
- Hematology 944
- Genetics 332
- Molecular Biology 1.5k
- Cancer Research 236
- Oncology 427
Countries citing papers authored by Björn W. Hackanson
This map shows the geographic impact of Björn W. Hackanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn W. Hackanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn W. Hackanson more than expected).
Fields of papers citing papers by Björn W. Hackanson
This network shows the impact of papers produced by Björn W. Hackanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn W. Hackanson. The network helps show where Björn W. Hackanson may publish in the future.
Co-authors
The 25 scholars most cited alongside Björn W. Hackanson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 343 | |
| 2 | 2007 | 294 | |
| 3 | 2018 | 237 | |
| 4 | 2011 | 204 | |
| 5 | 2005 | 178 | |
| 6 | 2008 | 121 | |
| 7 | 2006 | 106 | |
| 8 | 2005 | 96 | |
| 9 | 2007 | 75 | |
| 10 | 2019 | 74 | |
| 11 | 2007 | 74 | |
| 12 | 2008 | 65 | |
| 13 | 2014 | 60 | |
| 14 | 2014 | 58 | |
| 15 | 2012 | 46 | |
| 16 | 2015 | 45 | |
| 17 | 2014 | 44 | |
| 18 | 2009 | 40 | |
| 19 | 2011 | 35 | |
| 20 | 2016 | 33 |
About Björn W. Hackanson
Björn W. Hackanson is a scholar working on Hematology, Genetics, Molecular Biology, Oncology and Public Health, Environmental and Occupational Health, having authored 60 papers that have together received 2.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (32 papers), Epigenetics and DNA Methylation (19 papers), Histone Deacetylase Inhibitors Research (12 papers), Acute Lymphoblastic Leukemia research (8 papers), Protein Degradation and Inhibitors (6 papers), Chronic Myeloid Leukemia Treatments (6 papers), Genomics and Chromatin Dynamics (5 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Hematology (944 citations), Genetics (332 citations), Molecular Biology (1.5k citations), Cancer Research (236 citations) and Oncology (427 citations). Björn W. Hackanson has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Michael Lübbert, Manfred Jung, Julia M. Wagner, Christoph Plass, Michael Daskalakis, Rainer Claus, Romulo Martin Brena, Claudia Schmoor, Konstanze Döhner and Nadja Blagitko‐Dorfs. Their work appears in journals such as Blood, Annals of Oncology, Annals of Hematology, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.